Stapokibart shows promise in reducing nasal congestion in seasonal allergy patients, study finds Post author: Post published:February 9, 2024 Post category:uncategorized The efficacy and safety of stapokibart as an in patients with seasonal allergic rhinitis (SAR). You Might Also Like New service could cut hospital admissions for older adults and save NHS money February 24, 2025 Targeting CD47 protein could improve colorectal cancer treatment November 7, 2024 Mount Sinai launches AI center to revolutionize small molecule drug discovery April 2, 2025